A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines

• Rhea N. Coler ,

  Contributed equally to this work with: Rhea N. Coler, Susan L. Baldwin

  Affiliation Infectious Disease Research Institute, Seattle, Washington, United States of America

  ⨯
• Susan L. Baldwin ,

  Contributed equally to this work with: Rhea N. Coler, Susan L. Baldwin

  Affiliation Infectious Disease Research Institute, Seattle, Washington, United States of America

  ⨯
• Narek Shaverdian,

  Affiliation Infectious Disease Research Institute, Seattle, Washington, United States of America

  ⨯
• Sylvie Bertholet,

  Affiliation Infectious Disease Research Institute, Seattle, Washington, United States of America

  ⨯
• Steven J. Reed,

  Affiliation Infectious Disease Research Institute, Seattle, Washington, United States of America

  ⨯
• Vanitha S. Raman,

  Affiliation Infectious Disease Research Institute, Seattle, Washington, United States of America

  ⨯
• Xiuhua Lu,

  Affiliation National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Joshua DeVos,

  Affiliation National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Kathy Hancock,

  Affiliation National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Jacqueline M. Katz,

  Affiliation National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Thomas S. Vedvick,

  Affiliation Infectious Disease Research Institute, Seattle, Washington, United States of America

  ⨯
• Malcolm S. Duthie,

  Affiliation Infectious Disease Research Institute, Seattle, Washington, United States of America

  ⨯
• Christopher H. Clegg,

  Affiliation Immune Design Corporation, Seattle, Washington, United States of America

  ⨯
• Neal Van Hoeven,

  Affiliation Immune Design Corporation, Seattle, Washington, United States of America

  ⨯
• Steven G. Reed

  * E-mail: sreed@idri.org

  Affiliations Infectious Disease Research Institute, Seattle, Washington, United States of America, Immune Design Corporation, Seattle, Washington, United States of America

  ⨯